Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, September 1, 2025

Automated ischemic stroke lesion detection on non-contrast brain CT: a large-scale clinical feasibility test AI stroke lesion detection on NCCT

This is totally fucking useless without the followup protocols that deliver recovery! Why are you stopping at the first step? Diagnosing something without a recovery plan is the height of stupidity!

Automated ischemic stroke lesion detection on non-contrast brain CT: a large-scale clinical feasibility test AI stroke lesion detection on NCCT


  • 1Department of Neurology, Yonsei University College of Medicine, Seoul, Republic of Korea
  • 2Artificial Intelligence Research Center, JLK Inc., Seoul, Republic of Korea
  • 3Department of Neurology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Republic of Korea
  • 4Department of Neurology, Korea University Guro Hospital and Korea University College of Medicine, Seoul, Republic of Korea
  • 5Department of Neurology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea
  • 6Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
  • 7Department of Diagnostic Imaging, Foothills Medical Center, University of Calgary, Calgary, AB, Canada
  • 8Department of Clinical Neurosciences, Foothills Medical Center, University of Calgary, Calgary, AB, Canada
  • 9Department of Neurology, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada
  • 10Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea

Background: Non-contrast CT (NCCT) is widely used imaging modality for acute stroke imaging but often fails to detect subtle early ischemic changes. Such underestimation can lead clinicians to overlook tissue-level information. This study aimed to develop and externally validate automated software for detecting ischemic lesions on NCCT and to assess its clinical feasibility in stroke patients undergoing endovascular thrombectomy.

Methods: In this retrospective, multicenter cohort study (May 2011–April 2024), a modified 3D U-Net model was trained using paired NCCT and diffusion-weighted imaging (DWI) data from 2,214 patients with acute ischemic stroke. External validation was performed in 458 subjects. Clinical feasibility was assessed in 603 endovascular thrombectomy-treated patients with complete recanalization. Model outputs were compared against expert-annotated DWI lesions for sensitivity, specificity, and volumetric correlation. Clinical endpoints included follow-up DWI lesion volumes, hemorrhagic transformation, and 3-month modified Rankin Scale outcomes.

Results: A total of 458 subjects were evaluated for external validation (mean age, 64 years ± 16; 265 men). The model achieved 75.3% sensitivity (95% CI, 70.9–79.9%) and 79.1% specificity (95% CI, 77.1–81.3%). In the feasibility cohort (n = 603; mean age, 69 years ± 13; 362 men), NCCT-derived lesion volumes correlated with follow-up DWI volumes (ρ = 0.60, p < 0.001). Lesions >50 mL were associated with reduced favorable outcomes (17.3% [26/150] vs. 54.2% [246/453], p < 0.001) and higher hemorrhagic transformation rates (66.0% [99/150] vs. 46.3% [210/453], p < 0.001). Radiomics features improved hemorrhagic transformation prediction beyond clinical variables alone (area under the receiver operating characteristic curve, 0.833 vs. 0.626; p = 0.003).

Conclusion: The automated NCCT-based lesion detection model demonstrated reliable diagnostic performance and provided clinically relevant prognostic information in endovascular thrombectomy-treated stroke patients.

Introduction

Non-contrast computed tomography (NCCT) is the most widely accessible imaging modality for acute stroke worldwide due to its accessibility and utility in rapidly ruling out hemorrhagic stroke (Kurz et al., 2016). However, hypodense changes indicative of acute ischemia can be subtle, leading to suboptimal sensitivity (van Horn et al., 2021). Although semiquantitative scores are routinely used to communicate the extent of ischemic changes, their inter-rater reliability varies considerably (Farzin et al., 2016). Likewise, manual segmentation of early ischemic changes on NCCT often yields low agreement (Christensen et al., 2023).

Despite these limitations, the initial NCCT scan contains useful tissue-level information such as extent and severity of ischemia, which has not been thoroughly utilized in clinical practice (Demeestere et al., 2025). Greater emphasis on detecting and quantifying ischemic changes could guide treatment decisions, especially for time-sensitive interventions such as intravenous thrombolysis and endovascular treatment (EVT).

We aimed to develop an automated software model to detect acute ischemic lesions on NCCT. The model’s training and validation used concomitant diffusion-weighted imaging (DWI) with expert ratings as a reference standard, given DWI’s high sensitivity for acute infarction. We further tested the software’s clinical feasibility in a separate cohort of patients with large vessel occlusion (LVO) undergoing EVT with complete recanalization, correlating NCCT-derived lesion volumes and radiomics features with subsequent DWI and clinical outcomes.

Methods

The study conformed to the Standards for Reporting of Diagnostic Accuracy Studies guidelines for diagnostic accuracy research (Cohen et al., 2016).

Acute ischemic lesion detection on NCCT: model development and validation

We retrospectively collected data from six stroke centers in South Korea between 2011 and 2015, including 2,398 ischemic stroke patients. Inclusion required adults with acute ischemic stroke who underwent NCCT and DWI within 3 h to minimize ischemic lesion evolution, while patients with poor image quality, structural brain abnormalities, or incomplete expert annotations were excluded (Figure 1A). Five expert neurologists each with over 10 years of clinical experience, manually annotated ischemic lesions visible on NCCT while referring to DWI / apparent diffusion coefficient images for confirmation. Experts’ annotation agreements were assessed using volumetric similarity indices and absolute volume difference, with ground truth defined by consensus of more than 2 experts. The labeled 2,398 ischemic stroke patients were randomly categorized into 2,214 cases for training / internal validation cohort and 184 cases for external validation cohort with 274 non-stroke individuals.

No comments:

Post a Comment